Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001019

Drug Information
NameEstriol
Synonyms1,3,5(10)-Estratriene-3,16.alpha., 17.beta.-triol; Tridestrin; DB04573; 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol; D00185; Ovestrion; BRN 2508172; Orgastyptin; ZINC03815418; estriol; Orestin; HSDB 3590; Prestwick2_001096; Oestriol; CID5756; Oestriolum; Theelol; Overstin; A 13610; BPBio1_001290; 16-alpha,17-beta-Oestriol; 16.alpha.,17.beta.-Estriol; 16.alpha.-Hydroxyoestradiol; 46565_RIEDEL; BSPBio_001172; Hormomed; Prestwick3_001096; E0218; 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-oestratriene; Synapause; MLS000069812; 16.alpha.-Hydroxy-17.beta.-estradiol; Destriol; E1253_SIGMA; SMR000059210; Thulol; BRD-K17016787-001-03-5; Deuslon A; Estriol [USAN:JAN]; 16,17-Epiestriol; 16-Hydroxyestradiol; Oestra-1,3,5(10)-triene-3,16.alpha.,17.beta.-triol; 3,16.alpha.,17.beta.-Estriol; Estriolo [Italian]; 16-Epiestriol; Holin; 50-27-1; Estratriol; Estriel (TN); SMP1_000122; 3,16alpha,17beta-Trihydroxy-delta-1,3,5-oestratriene; Triodurin; Klimoral; SPBio_003056; Stiptanon; E1149_SIGMA; Deuslon-A; S2466_Selleck; 16-alpha-Hydroxyestradiol; CCRIS 284; Trihydroxyoestrin; NSC 12169; CHEMBL193482; Estriol (JP15/USP); Estra-1,3,5(10)-triene-3,16,17-triol, (16alpha,17beta)-; Estra-1,3,5(10)-trien-3,16.alpha.,17.beta.-triol; Estra-1,3,5(10)-trien-3,16alpha,17beta-triol; 3,16-alpha,17-beta-Trihydroxyoestra-1,3,5(10)-triene; 16.alpha.-Estriol; Oestra-1,3,5(10)-triene-3,16-alpha,17-beta-triol; HMS1571K14; 6EC6F23B-A991-4606-8BC7-146D915DAB31; Ortho-Gynest; Estriolo; Estra-1,3,5(10)-triene-3,16,17-triol; nchembio.76-comp38; Hormonin; Gynaesan; 16.alpha.-Hydroxyestradiol; Ovestin; Folicular hormone; Hemostyptanon; 3,16-alpha,17-beta-Trihydroxy-delta-1,3,5-estratriene; 4-06-00-07550 (Beilstein Handbook Reference); Triovex; 3,16.alpha.,17.beta.-Trihydroxyestra-1,3,5(10)-triene; Estra-1,3,5(10)-triene-3,16,17-triol, (16.alpha.,17.beta.)-; 16-alpha-Hydroxyoestradiol; CHEBI:27974; 3,16-alpha,17-beta-Trihydroxyestra-1,3,5(10)-triene; BIDD:ER0124; 16alpha-Hydroxyoestradiol; 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-oestratriene; Follicular hormone hydrate; 16alpha,17beta-Estriol; LMST02010003; 3,16alpha,17beta-Trihydroxy-1,3,5(10)-estratriene; Oestra-1,3,5(10)-triene-3,16.alpha., 17.beta.-triol; Trihydroxyestrin; WLN: L E5 B666TTT&J E1 FQ GQ OQ; 16alpha-Hydroxyestradiol; 1,3,5-Estratriene-3.beta.,16-.alpha.,17-.beta.-triol; C05141; Prestwick1_001096; (16.alpha.,17.beta.)-Oestra-1,3,5(10)-triene-3,16,17-triol; 16-alpha,17-beta-Estriol; C18H24O3; 16alpha-Hydroxy-17beta-estradiol; 3,16-alpha,17-beta-Estriol; AB00514045; Oestra-1,3,5(10)-triene-3,16alpha,17beta-triol; 1,3,5-Estratriene-3beta,16alpha,17beta-triol; 1,3,5-Oestratriene-3beta,16alpha,17beta-triol; OE3; estra-1(10),2,4-triene-3,16,17-triol, (16alpha,17beta)-; Estra-1,3,5(10)-triene-3,16.alpha., 17.beta.-triol; 3,16alpha,17beta-Estriol; 1,3,5-Oestratriene-3-.beta.,16.alpha.,17.beta.-triol; Estra-1,3,5(10)-triene-3,16alpha,17beta-triol; Oestratriol; NCGC00179277-01; 3,16.alpha.,17.beta.-Trihydroxy-.delta.-1,3,5-estratriene; 1,3,5(10)-Estratriene-3,16.alpha.,17.beta.-triol; Aacifemine; HMS2090E20; EINECS 200-022-2; Estra-1,3,5(10)-trien-3,16.alpha., 17.beta.-triol; Oestriol [Steroidal oestrogens]; 3,16.alpha.,17.beta.-Trihydroxy-1,3,5(10)-estratriene; (16.alpha.,17.beta.)-Estra-1,3,5(10)-triene-3,16,17-triol; NSC12169; Estriol, unconjugated; 46565_FLUKA; NSC-12169; (16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol; 3,16-alpha,17-beta-Oestriol; LS-64877; Prestwick0_001096; 16alpha,17beta-Oestriol; Estriel; 1,3,5(10)-ESTRATRIENE-3,16,17-TRIOL; 1,3,5(10)-Estratriene-3,16alpha,17beta-Triol; 3,16alpha,17beta-trihydroxy-Delta(1,3,5)-estratriene; 16.alpha.,17.beta.-Oestriol; ESL; (16alpha,17beta)-Oestra-1,3,5(10)-triene-3,16,17-triol; AC1L1L2H; Estra-1,3,5(10)-triene-3,16.alpha.,17.beta.-triol
IndicationMultiple sclerosis
[ICD9: 340   ICD10: G35]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-1
6(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16
-,17+,18+/m1/s1
InChIKeyPROQIPRRNZUXQM-ZXXIGWHRSA-N
Canonical SMILESCC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O    
Isomeric SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O
Therapeutic ClassEstrogens
CAS NumberCAS 50-27-1
FormulaC18H24O3
PubChem Compound IDCID 5756.
PubChem Substance IDSID 7560.
ChEBI27974;
SuperDrug ATC IDG03CA04; G03CC06
SuperDrug CAS ID000050271;
TargetEstrogen receptorAgonist[2]
Ref 1Drug information of Estriol, 2008 To Reference
Ref 2Reprint of Are all estrogens the same? Maturitas. 2008 Sep-Oct;61(1-2):195-201. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543